Psych MEQs / SAQs · Consultation-liaison psychiatry
Rapidly progressive dementia and prion disease (MEQ)
FRANZCP-style modified essay on rapidly progressive dementia: the tempo rule, the treatable-causes-first sieve, correct interpretation of CSF 14-3-3 and RT-QuIC, MRI and EEG performance, staged disclosure, infection-control and genetic counselling duties, and palliative planning.
On this page & tools
Target exams
(i) Assessment and investigation — 6 marks
Start with tempo, not mood. Date-anchored collateral, a function-based timeline, and the question "what could he do three months ago that he cannot do today?" A family who can name a week is describing a rapidly progressive dementia, and that reordering of the differential is the mark-earning move.[11]
Examine as a physician. Startle myoclonus, gait and limb ataxia, cortical visual function, tone, reflexes and primitive reflexes — the signs that were present in prion-negative as well as prion-positive patients, and which are missed if you only take a psychiatric history.[12][1]
Investigations, sequenced:[11][1][2]
- Bloods for reversible causes: B12, thiamine status, thyroid function, liver and renal function, calcium, glucose, syphilis and HIV serology, autoimmune and paraneoplastic screens.
- MRI with DWI and ADC — the request that decides the diagnosis; a routine sequence set can be reported normal when DWI is diagnostic.
- EEG, including consideration of non-convulsive status epilepticus.
- CSF: cell count, protein, 14-3-3, total tau, RT-QuIC, cytology and autoimmune encephalitis antibodies.
- PRNP sequencing where indicated, through the appropriate pathway.[1][2][13][17]
You have read the opening of this meqs / saq. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship atlas.
References20Show ledgerHide ledger
- [1]Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease Brain, 2009.PMID 19773352
- [2]Hermann P, Appleby B, Brandel JP, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease Lancet Neurol, 2021.PMID 33609480
- [3]Watson N, Brandel JP, Green A, et al. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease Nat Rev Neurol, 2021.PMID 33972773
- [4]Ladogana A, Puopolo M, Croes EA, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada Neurology, 2005.PMID 15883321
- [5]Appleby BS, Rincon-Beardsley TD, Appleby KK, et al. Initial diagnoses of patients ultimately diagnosed with prion disease J Alzheimers Dis, 2014.PMID 24934543
- [6]Zeidler M, Johnstone EC, Bamber RW, et al. New variant Creutzfeldt-Jakob disease: psychiatric features Lancet, 1997.PMID 9314868
- [7]Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK Lancet, 1996.PMID 8598754
- [8]Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease Lancet, 2000.PMID 10791525
- [9]Brown P, Brandel JP, Sato T, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment Emerg Infect Dis, 2012.PMID 22607808
- [10]Mead S, Hermann P, Mok TH, et al. Genetic causes and modifiers of prion diseases Lancet Neurol, 2026.PMID 41579904
- [11]Day GS Rapidly Progressive Dementia Continuum (Minneap Minn), 2022.PMID 35678409
- [12]Chitravas N, Jung RS, Kofskey DM, et al. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease Ann Neurol, 2011.PMID 21674591
- [13]Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis Lancet Neurol, 2016.PMID 26906964
- [14]Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias Neurology, 2011.PMID 21471469
- [15]Steinhoff BJ, Zerr I, Glatting M, et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease Ann Neurol, 2004.PMID 15449324
- [16]Muayqil T, Gronseth G, Camicioli R Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology Neurology, 2012.PMID 22993290
- [17]Foutz A, Appleby BS, Hamlin C, et al. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid Ann Neurol, 2017.PMID 27893164
- [18]Pocchiari M, Puopolo M, Croes EA, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies Brain, 2004.PMID 15361416
- [19]Williams RT, White N, Kearns J, et al. Palliative care symptoms of people living with rapidly progressive prion diseases: a systematic review BMC Palliat Care, 2026.PMID 42046045
- [20]Stevenson M, Uttley L, Oakley JE, et al. Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review Health Technol Assess, 2020.PMID 32122460